DNA damage-related gene expression as biomarkers to assess cellular response after gamma irradiation of a human lymphoblastoid cell line
- 17 February 2000
- journal article
- Published by Springer Nature in Oncogene
- Vol. 19 (7) , 916-923
- https://doi.org/10.1038/sj.onc.1203405
Abstract
Since defects in molecular mechanisms controlling DNA repair, cell cycle checkpoint and apoptosis could modify cellular sensitivity to DNA damaging agents, we have conducted a multiparametric molecular analysis for better understanding the regulation pathways leading to cell survival or cell death after irradiation. Using a human lymphoblastoid cell line, we have analysed, following gamma irradiation (0.5, 1, 2, 4, 8, 16 and 32 Gy, at 0.5, 24, 48 and 72 h after treatment), the correlation between proliferation, cell cycle analysis, apoptosis and micronuclei frequency with the expression of TP53, WAF1, DNA LIGASE 1, PCNA, BAX, BLC-2, BAK, DAD1, ICH1-Long and -Short forms mRNAs. We have found that whereas TP53, BAK, ICH1-Short form, and DAD1 were expressed at constant levels, WAF1, PCNA, BAX were up-regulated, ICH1-Long form, DNA LIGASE 1, and BCL-2 were down-regulated. These modifications of expression were significantly correlated with doses, survival, proliferation, cell cycle delays, and apoptosis. A positive correlation of WAF1 and BAX, and a borderline negative correlation with BCL-2 expressions were observed with micronuclei frequency for doses ranging from 0.5 to 4 Gy. In conclusion, our data clearly demonstrate that gene expression profiling, which is easier and more rapid to conduct than the assessments of classical phenotypic responses, could be useful to improve knowledge concerning pathways involved in cellular response to irradiation, knowing that such biomarkers could constitute tools to assess radio-sensitivity/radio-resistance. Oncogene (2000) 19, 916 - 923.Keywords
This publication has 35 references indexed in Scilit:
- p53 Suppresses the Activation of the Bcl-2 Promoter by the Brn-3a POU Family Transcription FactorJournal of Biological Chemistry, 1999
- Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stressOncogene, 1998
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- Regulation ofp53downstream genesSeminars in Cancer Biology, 1998
- Nuclear Accumulation of p21Cip1 at the Onset of Mitosis: a Role at the G2/M-Phase TransitionMolecular and Cellular Biology, 1998
- The advantages and disadvantages of the cytokinesis-block micronucleus methodMutation Research - Genetic Toxicology and Environmental Mutagenesis, 1997
- French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumoursLeukemia, 1997
- Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapyCancer, 1996
- p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.Proceedings of the National Academy of Sciences, 1995
- p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genesNature, 1994